76 studies found for:    Pulmonary Hypertension | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Hypertension | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
2 Recruiting Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Conditions: Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Tadalafil;   Drug: placebo
3 Recruiting Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Conditions: Persistent Pulmonary Hypertension;   Respiratory Failure
Interventions: Drug: Intravenous Sildenafil;   Other: Placebo
4 Recruiting Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
5 Recruiting Hydroxyurea in Pulmonary Arterial Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Hydroxyurea
6 Not yet recruiting Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
Conditions: Heart Failure;   Pulmonary Hypertension
Interventions: Drug: Tadalafil;   Drug: Placebo
7 Unknown  Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension;   PAH WHO Group I
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
8 Recruiting PAHTCH (Carvedilol)
Condition: Pulmonary Hypertension
Interventions: Drug: Carvedilol;   Drug: Carvedilol placebo
9 Recruiting Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Inhaled Nitric Oxide (iNO);   Drug: Nitrogen (placebo)
10 Recruiting Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™;   Device: STEEN Solution™
11 Recruiting Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: Spironolactone;   Drug: Placebo
12 Recruiting Pharmacokinetics of Sildenafil in Premature Infants
Condition: Persistent Pulmonary Hypertension of the Newborn
Intervention: Drug: 1 dose of sildenafil
13 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
14 Recruiting Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Conditions: Pulmonary Disease;   Pulmonary Hypertension
Intervention:
15 Recruiting Real-time MRI Right Heart Catheterization Using Passive Catheters
Conditions: Caridovascular Disease;   Congenital Heart Disease;   Pulmonary Hypertension
Interventions: Device: Balloon catheter for right heart catheterization;   Drug: Gadopentate Dimeglumine (Gadolinium); Contrast Agent;   Procedure: Right Heart Catheterization;   Procedure: Cardiac Real-time MRI;   Procedure: Vascular Hemostasis
16 Recruiting A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Conditions: Pulmonary Arterial Hypertension;   Systemic Sclerosis;   Scleroderma Spectrum of Diseases;   Connective Tissue Disease;   Pulmonary Hypertension
Interventions: Drug: Tadalafil monotherapy;   Drug: Ambrisentan monotherapy;   Drug: tadalafil and ambrisentan
17 Recruiting The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonitis;   Desquamative Interstitial Pneumonia
Intervention: Other: Aerobic Exercise Training
18 Recruiting Spironolactone for Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Spironolactone;   Drug: Placebo
19 Unknown  Effects of Viagra on Heart Function in Patients With Heart Failure
Conditions: Heart Failure;   Left Ventricular Dysfunction
Intervention: Drug: sildenafil
20 Recruiting SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
Conditions: Scleroderma, Systemic;   Sclerosis
Intervention: Behavioral: Telephone Call

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years